Randy E. Dobbs Sells 36,261 Shares of Viemed Healthcare, Inc. (NASDAQ:VMD) Stock

Viemed Healthcare, Inc. (NASDAQ:VMD) Director Randy E. Dobbs sold 36,261 shares of the stock in a transaction that occurred on Wednesday, November 13th. The stock was sold at an average price of $9.28, for a total transaction of $336,502.08. Following the sale, the director now owns 107,706 shares in the company, valued at approximately $999,511.68. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Viemed Healthcare Stock Down 2.7 %

Shares of Viemed Healthcare stock traded down $0.25 during trading hours on Wednesday, reaching $9.15. 254,507 shares of the company were exchanged, compared to its average volume of 154,050. The firm has a market cap of $356.30 million, a PE ratio of 34.07 and a beta of 1.43. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.19 and a current ratio of 1.31. Viemed Healthcare, Inc. has a 1 year low of $6.21 and a 1 year high of $10.44. The stock’s fifty day moving average is $8.28 and its 200 day moving average is $7.52.

Viemed Healthcare (NASDAQ:VMD) last issued its quarterly earnings results on Wednesday, November 6th. The company reported $0.10 earnings per share for the quarter, topping the consensus estimate of $0.08 by $0.02. The company had revenue of $58.00 million for the quarter. Viemed Healthcare had a return on equity of 8.72% and a net margin of 4.87%.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in VMD. Russell Investments Group Ltd. lifted its holdings in Viemed Healthcare by 5.3% during the 1st quarter. Russell Investments Group Ltd. now owns 146,952 shares of the company’s stock worth $1,386,000 after buying an additional 7,386 shares during the last quarter. Pinnacle Wealth Planning Services Inc. acquired a new position in Viemed Healthcare in the first quarter valued at approximately $135,000. Vanguard Group Inc. boosted its holdings in Viemed Healthcare by 53.0% in the first quarter. Vanguard Group Inc. now owns 1,781,914 shares of the company’s stock valued at $16,803,000 after purchasing an additional 617,009 shares in the last quarter. Price T Rowe Associates Inc. MD acquired a new stake in Viemed Healthcare during the first quarter worth approximately $97,000. Finally, Kent Lake Capital LLC acquired a new stake in Viemed Healthcare during the first quarter worth approximately $5,557,000. Hedge funds and other institutional investors own 74.24% of the company’s stock.

About Viemed Healthcare

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.